Erythrocytosis /Increased Hematocrit : current and classic references

1. Berk PD. Epilogue: broader lessons from the study of polycythemia vera. Sem Hematol 1997;34:77-80.

2. Berlin NJ. Diagnosis and classification of the polycythemias. Semin Hematol 1976; 12:339.

3. Buetler E. Problems in the diagnosis of hemaglobinopathies and of polycythemia. Mayo Clin Proc 1991;66:102-104.

4. Casadevall N. Determination of serum erythropoietin. Its value in the differential diagnosis of polycythemias. Nouv Rev Fr Hematol 1994; 36(2):173-6.

5. Charache S, Weatherall DJ, Clegg JB. Polycythemia associated with a hemoglobinopathy. J Clin Invest 1966; 115:813.

6. El-Hemaidi I, Marsden JT, et al. Serum erythropoietin in the erythrocytoses : is a low value specific for polycythaemia vera ? Br J Haematol 2000; 108 (Suppl 1) : 235 (abstract).

7. Gilbert HS. Modern treatment strategies in polycythemia vera. Semin Hematol. 2003;40:26-9.

8. Kieclard L, Campier A, et al. Hemoglobin Nevers; a new silent variant found in France. Hemoglobin 1990; 14:103.

9. Kung C, et al. Polycythemia: Primary or Secondary: the differential diagnostic value of stem cell cultures. Schweiz Med Wochenschr 1993;123:53.

10. Landolfi R et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med 2004;350:114-24.

11. Lertzman M, Isreals LG, Chermiack RM. Erythropoiesis and ferrokinetics in chronic respiratory disease. Ann Intern Med 1962; 58:821.

12. McCann S, Foa R, Smith O, Conneally E. Case-Based Haematology. Blackwell 2005.

13. Messinezy M, Pearson TC. A retrospective study of apparent and relative polycythemias: associated factors and early outcome. Clin Lab Haematol 1990; 12:221.

14. Messinezy M, Pearson TC. Apparent polycythemia: diagnosis, pathogenesis and management. Eur J Haematol 1993; 51(3):125-31.

15. Messinezy M et al. Low serum erythropoietin - a strong diagnostic criterion of primary polycythemia even at normal haemoglobin levels. Clin Lab Haematol 1995; 17: 217.

16. Muldowney, FP. The relationship of total red cell mass to lean body mass in man. Clin Sci 1957; 16:163.

17. Najean Y, Rain J-D. The very long evolution of polycythemia vera: An analysis of 318 patients initially treated by phlebotomy or 32P between 1969 and 1981. Sem Hematol 1997;34:6-16.

18. Nathen R, Otis P, Martin DC. Polycythemia following renal transplantation. Urology 1975; 6:158.

19. Pearson TC. Diagnosis and classification of erythrocytoses and thrombocytoses. Bailleres Clin haematol 1998; 11: 695.

20. Rosenthal DS. Clinical aspects of chronic myeloproliferative diseases. Am J Med Sci 1992;304:109-124.

21. Sagone AL Jr, Balcerzak SP. Smoking as a cause of erythrocytosis. Ann Intern Med 1975; 82:512.

22. Shaw DB, Simpson T. Polycythemia in emphysema. Am J Med 1961; 30:135.

23. Spivak JL. Erythrocytosis. In Hoffman R, Benz EJ,Jr, ShattilSJ, Furie B, Cohen HJ, Silbestein LE (eds): Hematology. Basic Priciples and Practice. New York, NY, Churchill Livingstone,inc 1995;pp484-491.

24. Tefferi A, Thiele J, Orazi A et al. Proposals and rationale for revision of the World Health Organisation diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood.2007; 11; 1092 1097

25. Trimble M, Caro J Talalla A, et al. Secondary erythrocytosis due to a cerebellar hemangioblastoma: Demonstration of mRNA in the tumor. Blood 1991;78;599-601.

26. Waldman TA, Rosse WG, Swarm RL. The erythropoiesis-stimulating factors produced by tumors. Ann NY Acad Sci 1968; 149:509.

27. Yousef MK, Bakewell WS Jr. The Gaisbock syndrome. JAMA 1972; 220:864.

End of Page